Fiche publication


Date publication

avril 2024

Journal

Nanoscale advances

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BIANCO Alberto


Tous les auteurs :
Lin H, Del Rio Castillo AE, González VJ, Bonaccorso F, Vázquez E, Fadeel B, Bianco A

Résumé

Molybdenum disulfide is an emerging 2D material with several potential applications in medicine. Therefore, it is crucial to ascertain its biocompatibility. Mast cells are immune cells that are found in many organs and tissues in contact with the extracellular environment, and can be cultured from progenitor cells present in the bone marrow. Given the long period required for differentiation and proliferation of primary mast cells, human mast cell lines have emerged as a tractable model for biological and toxicological studies. Here, we compare two types of industrial MoS using CD34-derived primary human mast cells and the LAD2 cell line. Minimal effects were observed on early-stage activation endpoints such as β-hexosaminidase release and expression of surface markers of mast cell activation. Transmission electron microscopy revealed limited uptake of the tested materials. Overall, MoS was found to be biocompatible, and the LAD2 cell line was validated as a useful model of mast cells.

Référence

Nanoscale Adv. 2024 04 30;6(9):2419-2430